Crane Holdings, Co. Reports Third Quarter 2022 Results
Crane Holdings (NYSE:CR) reported a GAAP net loss of $1.06 per share for Q3 2022, impacted by a $2.89 per share loss from asbestos-related divestitures. Adjusted EPS decreased to $1.86 from $1.98 year-over-year. Total sales fell 9% to $815 million, with core sales growth of 2% overshadowed by divestiture impacts. The company reaffirmed 2022 adjusted EPS guidance at $7.58-$7.72. Despite challenges, including supply chain constraints, Crane reported strong order and backlog growth, indicating potential for future revenue acceleration.
- Adjusted EPS guidance reaffirmed at $7.58-$7.72.
- Core order growth of 10% and total backlog growth of 18%.
- Adjusted operating profit margin increased to 17.6%.
- GAAP net loss of $1.06 per share due to asbestos divestiture.
- Total sales decreased by $79 million, or 9%, compared to Q3 2021.
- Operating loss of $31 million, a significant decline from $145 million profit in Q3 2021.
Third Quarter 2022 Highlights
-
Significant progress towards previously announced separation, including the appointment of
Aaron W. Saak as Crane NXT President and CEO; Remain on-track to complete separation in earlyApril 2023 . -
GAAP net loss of
per share, inclusive of$1.06 per share after-tax loss on the August divestiture that permanently removed all asbestos related liabilities and obligations from Crane's balance sheet.$2.89 -
Adjusted earnings per diluted share (adjusted EPS) was
.$1.86 -
Adjusting midpoint of GAAP earnings per diluted share (EPS) guidance primarily to reflect the third quarter loss on the asbestos transaction, and narrowing to a range of
, from a range of$6.58 -$6.72 .$9.80 -$10.20 -
Reaffirming the midpoint of adjusted EPS guidance, and narrowing the range to
, from a range of$7.58 -$7.72 .$7.45 -$7.85
Third Quarter 2022 Results
Third quarter 2022 GAAP net loss per share of
Third quarter 2022 sales were
Core year-over-year order growth of
Third quarter 2022 GAAP operating loss of
Summary of Third Quarter 2022 Results
|
|
Third Quarter |
|
Change |
||||||||||
(dollars in millions) |
|
2022 |
|
2021 |
|
$ |
|
% |
||||||
Net sales |
|
$ |
815 |
|
|
$ |
894 |
|
|
$ |
(79 |
) |
|
(9)% |
Core sales |
|
|
|
|
|
|
17 |
|
|
|
||||
Foreign exchange |
|
|
|
|
|
|
(36 |
) |
|
(4)% |
||||
Divestiture impact |
|
|
|
|
|
|
(60 |
) |
|
(7)% |
||||
|
|
|
|
|
|
|
|
|
||||||
Operating (loss) profit |
|
$ |
(31 |
) |
|
$ |
145 |
|
|
$ |
(176 |
) |
|
NM |
Adjusted operating profit* |
|
$ |
144 |
|
|
$ |
146 |
|
|
$ |
(3 |
) |
|
(2)% |
|
|
|
|
|
|
|
|
|
||||||
Operating profit margin |
|
|
(3.8 |
%) |
|
|
16.2 |
% |
|
|
|
NM |
||
Adjusted operating profit margin* |
|
|
17.6 |
% |
|
|
16.4 |
% |
|
|
|
120bps |
||
*Please see the attached Non-GAAP Financial Measures tables |
Cash Flow and Other Financial Metrics
Cash used for operating activities in the first nine months of 2022 was
The Company held cash of
Third Quarter 2022 Segment Results
All comparisons detailed in this section refer to operating results for the third quarter 2022 versus the third quarter 2021.
Aerospace & Electronics
|
|
Third Quarter |
|
Change |
|||||||||||
(dollars in millions) |
|
|
2022 |
|
|
|
2021 |
|
|
$ |
|
% |
|||
Net sales |
|
$ |
167 |
|
|
$ |
169 |
|
|
$ |
(1 |
) |
|
(1 |
)% |
|
|
|
|
|
|
|
|
|
|||||||
Operating profit |
|
$ |
28 |
|
|
$ |
33 |
|
|
$ |
(4 |
) |
|
(13 |
)% |
|
|
|
|
|
|
|
|
|
|||||||
Operating profit margin |
|
|
16.9 |
% |
|
|
19.3 |
% |
|
|
|
(240bps) |
Sales of
Process Flow Technologies
|
|
Third Quarter |
|
Change |
|||||||||||
(dollars in millions) |
|
|
2022 |
|
|
|
2021 |
|
|
$ |
|
% |
|||
Net sales |
|
$ |
250 |
|
|
$ |
299 |
|
|
$ |
(49 |
) |
|
(16 |
)% |
Core sales |
|
|
|
|
|
|
26 |
|
|
9 |
% |
||||
Foreign exchange |
|
|
|
|
|
|
(15 |
) |
|
(5 |
)% |
||||
Divestiture impact |
|
|
|
|
|
|
(60 |
) |
|
(20 |
)% |
||||
|
|
|
|
|
|
|
|
|
|||||||
Operating profit |
|
$ |
41 |
|
|
$ |
44 |
|
|
$ |
(3 |
) |
|
(7 |
)% |
Adjusted operating profit* |
|
$ |
42 |
|
|
$ |
46 |
|
|
$ |
(4 |
) |
|
(9 |
)% |
|
|
|
|
|
|
|
|
|
|||||||
Operating profit margin |
|
|
16.5 |
% |
|
|
14.8 |
% |
|
|
|
170bps |
|||
Adjusted operating profit margin* |
|
|
16.8 |
% |
|
|
15.5 |
% |
|
|
|
130bps |
|||
*Please see the attached Non-GAAP Financial Measures tables |
Sales of
Payment & Merchandising Technologies
|
|
Third Quarter |
|
Change |
|||||||||||
(dollars in millions) |
|
|
2022 |
|
|
|
2021 |
|
|
$ |
|
% |
|||
Net sales |
|
$ |
335 |
|
|
$ |
366 |
|
|
$ |
(31 |
) |
|
(8 |
)% |
Core sales |
|
|
|
|
|
|
(10 |
) |
|
(3 |
)% |
||||
Foreign exchange |
|
|
|
|
|
|
(20 |
) |
|
(6 |
)% |
||||
|
|
|
|
|
|
|
|
|
|||||||
Operating profit |
|
$ |
87 |
|
|
$ |
84 |
|
|
$ |
3 |
|
|
4 |
% |
Adjusted operating profit* |
|
$ |
87 |
|
|
$ |
83 |
|
|
$ |
4 |
|
|
5 |
% |
|
|
|
|
|
|
|
|
|
|||||||
Operating profit margin |
|
|
25.9 |
% |
|
|
22.9 |
% |
|
|
|
300bps |
|||
Adjusted operating profit margin* |
|
|
25.9 |
% |
|
|
22.6 |
% |
|
|
|
330bps |
|||
*Please see the attached Non-GAAP Financial Measures tables |
Sales of
Engineered Materials
|
|
Third Quarter |
|
Change |
||||||||||
(dollars in millions) |
|
|
2022 |
|
|
|
2021 |
|
|
$ |
|
% |
||
Net sales |
|
$ |
63 |
|
|
$ |
60 |
|
|
$ |
3 |
|
4 |
% |
|
|
|
|
|
|
|
|
|
||||||
Operating profit |
|
$ |
7 |
|
|
$ |
7 |
|
|
$ |
— |
|
— |
% |
Adjusted operating profit* |
|
$ |
7 |
|
|
$ |
7 |
|
|
$ |
— |
|
— |
% |
|
|
|
|
|
|
|
|
|
||||||
Operating profit margin |
|
|
10.7 |
% |
|
|
10.9 |
% |
|
|
|
(20bps) |
||
Adjusted operating profit margin* |
|
|
10.8 |
% |
|
|
10.9 |
% |
|
|
|
(10bps) |
||
*Please see the attached Non-GAAP Financial Measures tables |
Sales of
2022 Outlook and Guidance
We are adjusting the midpoint of our full year 2022 GAAP EPS guidance primarily to reflect the third quarter after-tax charges of
We are reaffirming the midpoint of our adjusted EPS guidance, and narrowing the range to
We expect 2022 adjusted free cash flow (cash provided by operating activities less capital spending, and less the cash outflows associated with the divestiture of asbestos-related assets and liabilities and other portfolio actions) of
Conference Call
About
Forward-Looking Statements Disclaimer
This press release contains forward-looking statements within the meaning of the federal securities laws. Forward-looking statements include all statements that are not historical statements of fact and those regarding our intent, belief, or expectations, including, but not limited to: statements regarding Crane’s and the ultimate spin-off company’s (“SpinCo”) portfolio composition and their relationship following the business separation; the anticipated timing, structure, benefits, and tax treatment of the separation transaction; benefits and synergies of the separation transaction; strategic and competitive advantages of each of Crane and
Words such as “anticipate(s),” “expect(s),” “intend(s),” “plan(s),” “believe(s),” “may,” “will,” “would,” “could,” “should,” “seek(s),” and similar expressions, or the negative of these terms, are intended to identify such forward-looking statements. These statements are based on management’s current expectations and beliefs and are subject to a number of risks and uncertainties that could lead to actual results differing materially from those projected, forecasted or expected. Although we believe that the assumptions underlying the forward-looking statements are reasonable, we can give no assurance that our expectations will be attained.
Risks and uncertainties that could cause actual results to differ materially from our expectations include, but are not limited to: changes in global economic conditions (including inflationary pressures) and geopolitical risks, including macroeconomic fluctuations that may harm our business, results of operation and stock price; the continuing effects from the coronavirus pandemic on our business and the global and
Readers should carefully review Crane’s financial statements and the notes thereto, as well as the section entitled “Risk Factors” in Item 1A of Crane’s Annual Report on Form 10-K for the year ended
These forward-looking statements reflect management’s judgment as of this date, and Crane assumes no (and disclaims any) obligation to revise or update them to reflect future events or circumstances.
We make no representations or warranties as to the accuracy of any projections, statements or information contained in this document. It is understood and agreed that any such projections, targets, statements and information are not to be viewed as facts and are subject to significant business, financial, economic, operating, competitive and other risks, uncertainties and contingencies many of which are beyond our control, that no assurance can be given that any particular financial projections ranges, or targets will be realized, that actual results may differ from projected results and that such differences may be material. While all financial projections, estimates and targets are necessarily speculative, we believe that the preparation of prospective financial information involves increasingly higher levels of uncertainty the further out the projection, estimate or target extends from the date of preparation. The assumptions and estimates underlying the projected, expected or target results are inherently uncertain and are subject to a wide variety of significant business, economic and competitive risks and uncertainties that could cause actual results to differ materially from those contained in the financial projections, estimates and targets. The inclusion of financial projections, estimates and targets in this press release should not be regarded as an indication that we or our representatives, considered or consider the financial projections, estimates and targets to be a reliable prediction of future events.
This press release does not constitute an offer to sell, or a solicitation of an offer to buy, securities for sale.
(Financial Tables Follow)
Condensed Statements of Operations Data (in millions, except per share data) |
||||||||||||||||
|
Three Months Ended
|
|
Nine Months Ended
|
|||||||||||||
|
|
2022 |
|
|
|
2021 |
|
|
|
2022 |
|
|
|
2021 |
|
|
Net sales: |
|
|
|
|
|
|
|
|||||||||
Aerospace & Electronics |
$ |
167.2 |
|
|
$ |
168.6 |
|
|
$ |
485.8 |
|
|
$ |
480.2 |
|
|
Process Flow Technologies |
|
250.0 |
|
|
|
299.1 |
|
|
|
857.4 |
|
|
|
897.9 |
|
|
Payment & Merchandising Technologies |
|
335.1 |
|
|
|
365.8 |
|
|
|
1,001.7 |
|
|
|
1,031.4 |
|
|
Engineered Materials |
|
62.8 |
|
|
|
60.3 |
|
|
|
205.9 |
|
|
|
173.3 |
|
|
Total net sales |
$ |
815.1 |
|
|
$ |
893.8 |
|
|
$ |
2,550.8 |
|
|
$ |
2,582.8 |
|
|
|
|
|
|
|
|
|
|
|||||||||
Operating (loss) profit: |
|
|
|
|
|
|
|
|||||||||
Aerospace & Electronics |
$ |
28.2 |
|
|
$ |
32.5 |
|
|
$ |
84.4 |
|
|
$ |
89.3 |
|
|
Process Flow Technologies |
|
41.3 |
|
|
|
44.3 |
|
|
|
130.9 |
|
|
|
140.9 |
|
|
Payment & Merchandising Technologies |
|
86.7 |
|
|
|
83.7 |
|
|
|
251.6 |
|
|
|
247.4 |
|
|
Engineered Materials |
|
6.7 |
|
|
|
6.6 |
|
|
|
26.9 |
|
|
|
20.7 |
|
|
Corporate |
|
(31.7 |
) |
|
|
(22.3 |
) |
|
|
(91.2 |
) |
|
|
(62.5 |
) |
|
Loss on divestiture of asbestos-related assets and liabilities |
|
(162.4 |
) |
|
|
— |
|
|
|
(162.4 |
) |
|
|
— |
|
|
Total operating (loss) profit |
$ |
(31.2 |
) |
|
$ |
144.8 |
|
|
$ |
240.2 |
|
|
$ |
435.8 |
|
|
|
|
|
|
|
|
|
|
|||||||||
Interest income |
$ |
1.4 |
|
|
$ |
0.2 |
|
|
$ |
2.3 |
|
|
$ |
1.1 |
|
|
Interest expense |
|
(13.5 |
) |
|
|
(11.0 |
) |
|
|
(36.0 |
) |
|
|
(36.0 |
) |
|
Gain on sale of business |
|
3.8 |
|
|
|
— |
|
|
|
232.5 |
|
|
|
— |
|
|
Miscellaneous, net |
|
4.5 |
|
|
|
3.6 |
|
|
|
22.8 |
|
|
|
17.2 |
|
|
(Loss) income before income taxes |
|
(35.0 |
) |
|
|
137.6 |
|
|
|
461.8 |
|
|
|
418.1 |
|
|
Provision for income taxes |
|
24.3 |
|
|
|
21.0 |
|
|
|
157.9 |
|
|
|
54.8 |
|
|
Net (loss) income attributable to common shareholders |
$ |
(59.3 |
) |
|
$ |
116.6 |
|
|
$ |
303.9 |
|
|
$ |
363.3 |
|
|
|
|
|
|
|
|
|
|
|||||||||
(Loss) earnings per diluted share |
$ |
(1.06 |
) |
|
$ |
1.96 |
|
|
$ |
5.30 |
|
|
$ |
6.14 |
|
|
|
|
|
|
|
|
|
|
|||||||||
Average diluted shares outstanding |
|
56.1 |
|
|
|
59.5 |
|
|
|
57.3 |
|
|
|
59.2 |
|
|
Average basic shares outstanding |
|
56.1 |
|
|
|
58.7 |
|
|
|
56.5 |
|
|
|
58.5 |
|
|
|
|
|
|
|
|
|
|
|||||||||
Supplemental data: |
|
|
|
|
|
|
|
|||||||||
Cost of sales |
$ |
485.6 |
|
|
$ |
556.3 |
|
|
$ |
1,547.4 |
|
|
$ |
1,593.5 |
|
|
Selling, general & administrative |
|
198.3 |
|
|
|
192.7 |
|
|
|
600.8 |
|
|
|
553.5 |
|
|
Transaction related expenses 1 |
|
11.5 |
|
|
|
0.6 |
|
|
|
37.2 |
|
|
|
1.3 |
|
|
Repositioning related charges (gains), net 1 |
|
0.8 |
|
|
|
0.8 |
|
|
|
3.8 |
|
|
|
(8.6 |
) |
|
Depreciation and amortization 1 |
|
28.8 |
|
|
|
29.1 |
|
|
|
89.8 |
|
|
|
91.4 |
|
|
Stock-based compensation expense 1 |
|
5.9 |
|
|
|
6.2 |
|
|
|
17.8 |
|
|
|
18.6 |
|
|
|
|
|
|
|
|
|
|
|||||||||
1 Amounts included within Cost of sales and/or Selling, general & administrative costs. |
Condensed Balance Sheets (in millions) |
||||||
|
|
2022 |
|
2021 |
||
Assets |
|
|
|
|
||
Current assets |
|
|
|
|
||
Cash and cash equivalents |
|
$ |
438.6 |
|
$ |
478.6 |
Accounts receivable, net |
|
|
486.9 |
|
|
483.0 |
Current insurance receivable - asbestos |
|
|
— |
|
|
13.7 |
Inventories, net |
|
|
435.7 |
|
|
449.1 |
Other current assets |
|
|
121.1 |
|
|
118.7 |
Total current assets |
|
|
1,482.3 |
|
|
1,543.1 |
|
|
|
|
|
||
Property, plant and equipment, net |
|
|
493.9 |
|
|
555.6 |
Long-term insurance receivable - asbestos |
|
|
— |
|
|
60.0 |
Other assets |
|
|
659.1 |
|
|
744.1 |
|
|
|
1,497.1 |
|
|
1,583.8 |
Total assets |
|
$ |
4,132.4 |
|
$ |
4,486.6 |
|
|
|
|
|
||
Liabilities and equity |
|
|
|
|
||
Current liabilities |
|
|
|
|
||
Short-term borrowings |
|
$ |
399.5 |
|
$ |
— |
Accounts payable |
|
|
241.1 |
|
|
273.7 |
Current asbestos liability |
|
|
— |
|
|
62.3 |
Accrued liabilities |
|
|
395.9 |
|
|
442.7 |
Income taxes |
|
|
39.3 |
|
|
10.6 |
Total current liabilities |
|
|
1,075.8 |
|
|
789.3 |
|
|
|
|
|
||
Long-term debt |
|
|
843.2 |
|
|
842.4 |
Long-term deferred tax liability |
|
|
165.7 |
|
|
76.9 |
Long-term asbestos liability |
|
|
— |
|
|
549.8 |
Other liabilities |
|
|
336.9 |
|
|
393.1 |
|
|
|
|
|
||
Total equity |
|
|
1,710.8 |
|
|
1,835.1 |
Total liabilities and equity |
|
$ |
4,132.4 |
|
$ |
4,486.6 |
Condensed Statements of Cash Flows (in millions) |
||||||||||||||||
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
|
|
2022 |
|
|
|
2021 |
|
|
|
2022 |
|
|
|
2021 |
|
Operating activities: |
|
|
|
|
|
|
|
|
||||||||
Net (loss) income attributable to common shareholders |
|
$ |
(59.3 |
) |
|
$ |
116.6 |
|
|
$ |
303.9 |
|
|
$ |
363.3 |
|
Loss on divestiture of asbestos-related assets and liabilities |
|
|
148.9 |
|
|
|
— |
|
|
|
148.9 |
|
|
|
— |
|
Gain on sale of business |
|
|
(3.8 |
) |
|
|
— |
|
|
|
(232.5 |
) |
|
|
— |
|
Gain on sale of property |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(18.5 |
) |
Depreciation and amortization |
|
|
28.8 |
|
|
|
29.1 |
|
|
|
89.8 |
|
|
|
91.4 |
|
Stock-based compensation expense |
|
|
5.9 |
|
|
|
6.2 |
|
|
|
17.8 |
|
|
|
18.6 |
|
Defined benefit plans and postretirement credit |
|
|
(3.9 |
) |
|
|
(1.8 |
) |
|
|
(10.5 |
) |
|
|
(6.0 |
) |
Deferred income taxes |
|
|
0.3 |
|
|
|
(4.5 |
) |
|
|
20.2 |
|
|
|
(25.9 |
) |
Cash provided by (used for) operating working capital |
|
|
14.0 |
|
|
|
(12.2 |
) |
|
|
(135.0 |
) |
|
|
(41.3 |
) |
Defined benefit plans and postretirement contributions |
|
|
(10.7 |
) |
|
|
(5.6 |
) |
|
|
(19.3 |
) |
|
|
(22.8 |
) |
Environmental payments, net of reimbursements |
|
|
(0.4 |
) |
|
|
(1.0 |
) |
|
|
(5.4 |
) |
|
|
(4.6 |
) |
Asbestos related payments, net of insurance recoveries |
|
|
(5.9 |
) |
|
|
(9.4 |
) |
|
|
(29.3 |
) |
|
|
(29.6 |
) |
Divestiture of asbestos-related assets and liabilities |
|
|
(550.0 |
) |
|
|
— |
|
|
|
(550.0 |
) |
|
|
— |
|
Other |
|
|
9.1 |
|
|
|
2.9 |
|
|
|
23.4 |
|
|
|
2.4 |
|
Total (used for) provided by operating activities |
|
$ |
(427.0 |
) |
|
$ |
120.3 |
|
|
$ |
(378.0 |
) |
|
$ |
327.0 |
|
Investing activities: |
|
|
|
|
|
|
|
|
||||||||
Proceeds from disposition of capital assets |
|
$ |
— |
|
|
$ |
— |
|
|
$ |
0.1 |
|
|
$ |
23.3 |
|
Capital expenditures |
|
|
(11.6 |
) |
|
|
(12.1 |
) |
|
|
(36.8 |
) |
|
|
(26.7 |
) |
Proceeds from sale of business |
|
|
3.8 |
|
|
|
— |
|
|
|
318.1 |
|
|
|
— |
|
Purchase of marketable securities |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(10.0 |
) |
Proceeds from sale of marketable securities |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
40.0 |
|
Total (used for) provided by investing activities |
|
$ |
(7.8 |
) |
|
$ |
(12.1 |
) |
|
$ |
281.4 |
|
|
$ |
26.6 |
|
Financing activities: |
|
|
|
|
|
|
|
|
||||||||
Dividends paid |
|
$ |
(26.4 |
) |
|
$ |
(25.3 |
) |
|
$ |
(79.5 |
) |
|
$ |
(75.5 |
) |
Reacquisition of shares on open market |
|
|
— |
|
|
|
— |
|
|
|
(203.7 |
) |
|
|
— |
|
Stock options exercised, net of shares reacquired |
|
|
1.3 |
|
|
|
4.7 |
|
|
|
3.1 |
|
|
|
9.9 |
|
Repayments of commercial paper with maturities greater than 90 days |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(27.1 |
) |
Net borrowings from issuance of commercial paper with maturities of 90 days or less |
|
|
(119.4 |
) |
|
|
(15.0 |
) |
|
|
— |
|
|
|
— |
|
Proceeds from term loan |
|
|
399.4 |
|
|
|
— |
|
|
|
399.4 |
|
|
|
— |
|
Repayment of term loan |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(348.1 |
) |
Total provided by (used for) financing activities |
|
$ |
254.9 |
|
|
$ |
(35.6 |
) |
|
$ |
119.3 |
|
|
$ |
(440.8 |
) |
|
|
|
|
|
|
|
|
|
||||||||
Effect of exchange rate on cash and cash equivalents |
|
|
(32.1 |
) |
|
|
(8.5 |
) |
|
|
(62.7 |
) |
|
|
(13.0 |
) |
(Decrease) increase in cash and cash equivalents |
|
|
(212.0 |
) |
|
|
64.1 |
|
|
|
(40.0 |
) |
|
|
(100.2 |
) |
Cash and cash equivalents at beginning of period |
|
|
650.6 |
|
|
|
386.7 |
|
|
|
478.6 |
|
|
|
551.0 |
|
Cash and cash equivalents at end of period |
|
$ |
438.6 |
|
|
$ |
450.8 |
|
|
$ |
438.6 |
|
|
$ |
450.8 |
|
Order Backlog (in millions) |
|||||||||||||||
|
|
2022 |
|
2022 |
|
2022 |
|
2021 |
|
2021 |
|||||
Aerospace & Electronics |
|
$ |
591.6 |
|
$ |
534.4 |
|
$ |
508.4 |
|
$ |
459.8 |
|
$ |
478.5 |
Process Flow Technologies |
|
|
353.7 |
|
|
348.6 |
|
|
372.4 |
|
|
357.9 |
|
|
351.4 |
Payment & Merchandising Technologies |
|
|
499.8 |
|
|
482.0 |
|
|
429.0 |
|
|
438.0 |
|
|
387.9 |
Engineered Materials |
|
|
18.5 |
|
|
22.0 |
|
|
30.4 |
|
|
20.1 |
|
|
18.0 |
Total backlog |
|
$ |
1,463.6 |
|
$ |
1,387.0 |
|
$ |
1,340.2 |
|
$ |
1,275.8 |
|
$ |
1,235.8 |
Non-GAAP Financial Measures (in millions, except per share data) |
||||||||||||||||||
|
|
Three Months Ended |
|
|
||||||||||||||
|
|
2022 |
|
2021 |
|
% Change |
||||||||||||
|
|
$ |
|
Per Share |
|
$ |
|
Per Share |
|
(on $) |
||||||||
Net sales |
|
$ |
815.1 |
|
|
|
|
$ |
893.8 |
|
|
|
|
(8.8 |
)% |
|||
|
|
|
|
|
|
|
|
|
|
|
||||||||
Operating (loss) profit (GAAP) |
|
$ |
(31.2 |
) |
|
|
|
$ |
144.8 |
|
|
|
|
(121.5 |
)% |
|||
Operating profit margin (GAAP) |
|
|
(3.8 |
)% |
|
|
|
|
16.2 |
% |
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
||||||||
Special items impacting operating profit: |
|
|
|
|
|
|
|
|
|
|
||||||||
Loss on divestiture of asbestos-related assets and liabilities |
|
|
162.4 |
|
|
|
|
|
— |
|
|
|
|
|
||||
Transaction related expenses, net |
|
|
11.5 |
|
|
|
|
|
0.6 |
|
|
|
|
|
||||
Repositioning related charges, net |
|
|
0.8 |
|
|
|
|
|
0.8 |
|
|
|
|
|
||||
Adjusted operating profit |
|
$ |
143.5 |
|
|
|
|
$ |
146.2 |
|
|
|
|
(1.8 |
)% |
|||
Adjusted operating profit margin |
|
|
17.6 |
% |
|
|
|
|
16.4 |
% |
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
||||||||
Net (loss) income attributable to common shareholders (GAAP) |
|
$ |
(59.3 |
) |
|
$ |
(1.06 |
) |
|
$ |
116.6 |
|
|
$ |
1.96 |
|
(150.9 |
)% |
|
|
|
|
|
|
|
|
|
|
|
||||||||
Special items, net of tax, impacting net income attributable to common shareholders: |
|
|
|
|
|
|
|
|
|
|
||||||||
Loss on divestiture of asbestos-related assets and liabilities |
|
|
162.4 |
|
|
|
2.89 |
|
|
|
— |
|
|
|
— |
|
|
|
Transaction related expenses, net |
|
|
10.0 |
|
|
|
0.18 |
|
|
|
0.5 |
|
|
|
0.01 |
|
|
|
Repositioning related charges, net |
|
|
0.6 |
|
|
|
0.01 |
|
|
|
0.7 |
|
|
|
0.01 |
|
|
|
Interest expense on 364-Day Credit Agreement related to asbestos transaction |
|
|
1.6 |
|
|
|
0.03 |
|
|
|
— |
|
|
|
— |
|
|
|
Tax benefit related to divestiture of asbestos-related assets and liabilities |
|
|
(6.5 |
) |
|
|
(0.12 |
) |
|
|
— |
|
|
|
— |
|
|
|
Gain on sale of business |
|
|
(3.0 |
) |
|
|
(0.05 |
) |
|
|
— |
|
|
|
— |
|
|
|
Effect of potentially dilutive shares* |
|
|
|
|
(0.02 |
) |
|
|
|
|
|
|
||||||
Adjusted net income |
|
$ |
105.8 |
|
|
$ |
1.86 |
|
|
$ |
117.8 |
|
|
$ |
1.98 |
|
(10.2 |
)% |
*In the three months ended |
||||||||||||||||||
Average basic shares outstanding |
|
|
56.1 |
|
|
|
|
|
|
|
|
|
||||||
Effect of diluted shares |
|
|
0.7 |
|
|
|
|
|
|
|
|
|
||||||
Average shares outstanding including the effect of diluted shares |
|
|
56.8 |
|
|
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
||||||||
Special items impacting provision for income taxes: |
|
|
|
|
|
|
|
|
|
|
||||||||
Provision for income taxes (GAAP) |
|
$ |
24.3 |
|
|
|
|
$ |
21.0 |
|
|
|
|
|
||||
Tax effect of transaction related expenses, net |
|
|
1.5 |
|
|
|
|
|
0.1 |
|
|
|
|
|
||||
Tax effect of repositioning related charges, net |
|
|
0.2 |
|
|
|
|
|
0.2 |
|
|
|
|
|
||||
Tax effect of interest expense on 364-Day Credit Agreement related to asbestos transaction |
|
|
0.6 |
|
|
|
|
|
— |
|
|
|
|
|
||||
Tax effect of benefit related to divestiture of asbestos-related assets and liabilities |
|
|
6.5 |
|
|
|
|
|
— |
|
|
|
|
|
||||
Tax effect of gain on sale of business |
|
|
(0.8 |
) |
|
|
|
|
— |
|
|
|
|
|
||||
Adjusted provision for income taxes |
|
$ |
32.3 |
|
|
|
|
$ |
21.3 |
|
|
|
|
|
||||
Totals may not sum due to rounding |
|
|
|
|
|
|
|
|
|
|
Non-GAAP Financial Measures (in millions, except per share data) |
|||||||||||||||||||
|
|
Nine Months Ended |
|
|
|||||||||||||||
|
|
2022 |
|
2021 |
|
% Change |
|||||||||||||
|
|
$ |
|
Per Share |
|
$ |
|
Per Share |
|
(on $) |
|||||||||
Net sales |
|
$ |
2,550.8 |
|
|
|
|
$ |
2,582.8 |
|
|
|
|
(1.2 |
)% |
||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||
Operating profit (GAAP) |
|
$ |
240.2 |
|
|
|
|
$ |
435.8 |
|
|
|
|
(44.9 |
)% |
||||
Operating profit margin (GAAP) |
|
|
9.4 |
% |
|
|
|
|
16.9 |
% |
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||
Special items impacting operating profit: |
|
|
|
|
|
|
|
|
|
|
|||||||||
Loss on divestiture of asbestos-related assets and liabilities |
|
|
162.4 |
|
|
|
|
|
— |
|
|
|
|
|
|||||
Transaction related expenses, net |
|
|
37.2 |
|
|
|
|
|
1.3 |
|
|
|
|
|
|||||
Repositioning related charges (gains), net |
|
|
3.8 |
|
|
|
|
|
(8.6 |
) |
|
|
|
|
|||||
Adjusted operating profit |
|
$ |
443.6 |
|
|
|
|
$ |
428.5 |
|
|
|
|
3.5 |
% |
||||
Adjusted operating profit margin |
|
|
17.4 |
% |
|
|
|
|
16.6 |
% |
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||
Net income attributable to common shareholders (GAAP) |
|
$ |
303.9 |
|
|
$ |
5.30 |
|
|
$ |
363.3 |
|
|
$ |
6.14 |
|
|
(16.4 |
)% |
|
|
|
|
|
|
|
|
|
|
|
|||||||||
Special items, net of tax, impacting net income attributable to common shareholders: |
|
|
|
|
|
|
|
|
|
|
|||||||||
Loss on divestiture of asbestos-related assets and liabilities |
|
|
162.4 |
|
|
2.83 |
|
|
|
— |
|
|
|
— |
|
|
|
||
Transaction related expenses, net |
|
|
29.8 |
|
|
0.52 |
|
|
|
1.0 |
|
|
|
0.02 |
|
|
|
||
Repositioning related charges (gains), net |
|
|
2.8 |
|
|
|
0.05 |
|
|
|
(8.4 |
) |
|
|
(0.14 |
) |
|
|
|
Interest expense on 364-Day Credit Agreement related to asbestos transaction |
|
|
1.6 |
|
|
|
0.03 |
|
|
|
— |
|
|
|
— |
|
|
|
|
Tax benefit related to divestiture of asbestos-related assets and liabilities |
|
|
(6.5 |
) |
|
|
(0.11 |
) |
|
|
— |
|
|
|
— |
|
|
|
|
Impact of pension curtailments and settlements |
|
|
(0.9 |
) |
|
|
(0.02 |
) |
|
|
— |
|
|
|
— |
|
|
|
|
Gain on sale of business |
|
|
(184.5 |
) |
|
|
(3.22 |
) |
|
|
— |
|
|
|
— |
|
|
|
|
Deferred tax adjustment related to sale of business |
|
|
20.7 |
|
|
|
0.36 |
|
|
|
(21.5 |
) |
|
|
(0.36 |
) |
|
|
|
Gain on sale of property |
|
|
— |
|
|
|
— |
|
|
|
(4.5 |
) |
|
|
(0.08 |
) |
|
|
|
Adjusted net income |
|
$ |
329.3 |
|
|
$ |
5.75 |
|
|
$ |
329.9 |
|
|
$ |
5.58 |
|
|
(0.2 |
)% |
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||
Special items impacting provision for income taxes: |
|
|
|
|
|
|
|
|
|
|
|||||||||
Provision for income taxes (GAAP) |
|
$ |
157.9 |
|
|
|
|
$ |
54.8 |
|
|
|
|
|
|||||
Tax effect of transaction related expenses, net |
|
|
— |
|
|
|
|
|
0.3 |
|
|
|
|
|
|||||
Tax effect of repositioning related charges (gains), net |
|
|
1.1 |
|
|
|
|
|
(0.3 |
) |
|
|
|
|
|||||
Tax effect of interest expense on 364-Day Credit Agreement related to asbestos transaction |
|
|
0.6 |
|
|
|
|
|
— |
|
|
|
|
|
|||||
Tax effect of benefit related to divestiture of asbestos-related assets and liabilities |
|
|
6.5 |
|
|
|
|
|
— |
|
|
|
|
|
|||||
Tax effect of impact of pension curtailments and settlements |
|
|
(0.3 |
) |
|
|
|
|
— |
|
|
|
|
|
|||||
Tax effect of gain on sale of business |
|
|
(48.0 |
) |
|
|
|
|
— |
|
|
|
|
|
|||||
Tax effect of deferred tax adjustment related to sale of business |
|
|
(20.7 |
) |
|
|
|
|
21.5 |
|
|
|
|
|
|||||
Tax effect of gain on sale of property |
|
|
— |
|
|
|
|
|
(1.2 |
) |
|
|
|
|
|||||
Adjusted provision for income taxes |
|
$ |
97.1 |
|
|
|
|
$ |
75.1 |
|
|
|
|
|
|||||
Totals may not sum due to rounding |
|
|
|
|
|
|
|
|
|
|
Non-GAAP Financial Measures by Segment (in millions) |
||||||||||||||||||||||||
Three Months Ended |
Aerospace & Electronics |
|
Process Flow Technologies |
|
Payment & Merchandising Technologies |
|
Engineered Materials |
|
Corporate |
|
Total Company |
|||||||||||||
Net sales |
$ |
167.2 |
|
|
$ |
250.0 |
|
|
$ |
335.1 |
|
|
$ |
62.8 |
|
|
$ |
— |
|
|
$ |
815.1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Operating profit (loss) (GAAP) |
$ |
28.2 |
|
|
$ |
41.3 |
|
|
$ |
86.7 |
|
|
$ |
6.7 |
|
|
$ |
(194.1 |
) |
|
$ |
(31.2 |
) |
|
Operating profit margin (GAAP) |
|
16.9 |
% |
|
|
16.5 |
% |
|
|
25.9 |
% |
|
|
10.7 |
% |
|
|
|
|
(3.8 |
)% |
|||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Special items impacting operating profit: |
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Loss on divestiture of asbestos-related assets and liabilities |
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
162.4 |
|
|
$ |
162.4 |
|
|
Transaction related expenses |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
11.5 |
|
|
|
11.5 |
|
|
Repositioning related charges, net |
|
— |
|
|
|
0.7 |
|
|
|
— |
|
|
|
0.1 |
|
|
|
— |
|
|
|
0.8 |
|
|
Adjusted operating profit |
$ |
28.2 |
|
|
$ |
42.0 |
|
|
$ |
86.7 |
|
|
$ |
6.8 |
|
|
$ |
(20.2 |
) |
|
$ |
143.5 |
|
|
Adjusted operating profit margin |
|
16.9 |
% |
|
|
16.8 |
% |
|
|
25.9 |
% |
|
|
10.8 |
% |
|
|
|
|
17.6 |
% |
|||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Three Months Ended |
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Net sales |
$ |
168.6 |
|
|
$ |
299.1 |
|
|
$ |
365.8 |
|
|
$ |
60.3 |
|
|
$ |
— |
|
|
$ |
893.8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Operating profit (GAAP) |
$ |
32.5 |
|
|
$ |
44.3 |
|
|
$ |
83.7 |
|
|
$ |
6.6 |
|
|
$ |
(22.3 |
) |
|
$ |
144.8 |
|
|
Operating profit margin (GAAP) |
|
19.3 |
% |
|
|
14.8 |
% |
|
|
22.9 |
% |
|
|
10.9 |
% |
|
|
|
|
16.2 |
% |
|||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Special items impacting operating profit: |
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Transaction related expenses |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.6 |
|
|
|
0.6 |
|
|
Repositioning related charges (gains), net |
|
— |
|
|
|
1.9 |
|
|
|
(1.1 |
) |
|
|
— |
|
|
|
— |
|
|
|
0.8 |
|
|
Adjusted operating profit |
$ |
32.5 |
|
|
$ |
46.2 |
|
|
$ |
82.6 |
|
|
$ |
6.6 |
|
|
$ |
(21.7 |
) |
|
$ |
146.2 |
|
|
Adjusted operating profit margin |
|
19.3 |
% |
|
|
15.5 |
% |
|
|
22.6 |
% |
|
|
10.9 |
% |
|
|
|
|
16.4 |
% |
|||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Totals may not sum due to rounding |
Non-GAAP Financial Measures by Segment (in millions) |
||||||||||||||||||||||||
Nine Months Ended |
Aerospace & Electronics |
|
Process Flow Technologies |
|
Payment & Merchandising Technologies |
|
Engineered Materials |
|
Corporate |
|
Total Company |
|||||||||||||
Net sales |
$ |
485.8 |
|
|
$ |
857.4 |
|
|
$ |
1,001.7 |
|
|
$ |
205.9 |
|
|
$ |
— |
|
|
$ |
2,550.8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Operating profit (GAAP) |
$ |
84.4 |
|
|
$ |
130.9 |
|
|
$ |
251.6 |
|
|
$ |
26.9 |
|
|
$ |
(253.6 |
) |
|
$ |
240.2 |
|
|
Operating profit margin (GAAP) |
|
17.4 |
% |
|
|
15.3 |
% |
|
|
25.1 |
% |
|
|
13.1 |
% |
|
|
|
|
9.4 |
% |
|||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Special items impacting operating profit: |
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Loss on divestiture of asbestos-related assets and liabilities |
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
162.4 |
|
|
$ |
162.4 |
|
|
Transaction related expenses |
|
— |
|
|
|
4.2 |
|
|
|
— |
|
|
|
3.6 |
|
|
|
29.4 |
|
|
|
37.2 |
|
|
Repositioning related charges, net |
|
— |
|
|
|
3.7 |
|
|
|
— |
|
|
|
0.1 |
|
|
|
— |
|
|
|
3.8 |
|
|
Adjusted operating profit |
$ |
84.4 |
|
|
$ |
138.8 |
|
|
$ |
251.6 |
|
|
$ |
30.6 |
|
|
$ |
(61.8 |
) |
|
$ |
443.6 |
|
|
Adjusted operating profit margin |
|
17.4 |
% |
|
|
16.2 |
% |
|
|
25.1 |
% |
|
|
14.9 |
% |
|
|
|
|
17.4 |
% |
|||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Nine Months Ended |
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Net sales |
$ |
480.2 |
|
|
$ |
897.9 |
|
|
$ |
1,031.4 |
|
|
$ |
173.3 |
|
|
$ |
— |
|
|
$ |
2,582.8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Operating profit (GAAP) |
$ |
89.3 |
|
|
$ |
140.9 |
|
|
$ |
247.4 |
|
|
$ |
20.7 |
|
|
$ |
(62.5 |
) |
|
$ |
435.8 |
|
|
Operating profit margin (GAAP) |
|
18.6 |
% |
|
|
15.7 |
% |
|
|
24.0 |
% |
|
|
11.9 |
% |
|
|
|
|
16.9 |
% |
|||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Special items impacting operating profit: |
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Acquisition-related and integration charges |
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
1.3 |
|
|
$ |
1.3 |
|
|
Repositioning related charges (gains), net |
|
— |
|
|
|
(7.0 |
) |
|
|
(1.6 |
) |
|
|
— |
|
|
|
— |
|
|
|
(8.6 |
) |
|
Adjusted operating profit |
$ |
89.3 |
|
|
$ |
133.9 |
|
|
$ |
245.8 |
|
|
$ |
20.7 |
|
|
$ |
(61.2 |
) |
|
$ |
428.5 |
|
|
Adjusted operating profit margin |
|
18.6 |
% |
|
|
14.9 |
% |
|
|
23.8 |
% |
|
|
11.9 |
% |
|
|
|
|
16.6 |
% |
|||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Totals may not sum due to rounding |
Full Year Guidance (in millions, except per share data) |
||||||
2022 Earnings per Share Guidance |
|
Low |
|
High |
||
Earnings per diluted share (GAAP) |
|
$ |
6.58 |
|
$ |
6.72 |
Special items impacting earnings per share |
|
|
1.00 |
|
|
1.00 |
Adjusted earnings per diluted share |
|
$ |
7.58 |
|
$ |
7.72 |
|
|
Three Months Ended
|
|
Nine Months Ended
|
|
2022 Guidance |
||||||||||||||||||
Cash Flow Items |
|
|
2022 |
|
|
|
2021 |
|
|
|
2022 |
|
|
|
2021 |
|
|
Low |
|
High |
||||
Cash (used for) provided by operating activities |
|
$ |
(427.0 |
) |
|
$ |
120.3 |
|
|
$ |
(378.0 |
) |
|
$ |
327.0 |
|
|
$ |
(205.0 |
) |
|
$ |
(165.0 |
) |
Less: Capital expenditures |
|
|
(11.6 |
) |
|
|
(12.1 |
) |
|
|
(36.8 |
) |
|
|
(26.7 |
) |
|
|
(60.0 |
) |
|
|
(60.0 |
) |
Free cash flow |
|
$ |
(438.6 |
) |
|
$ |
108.2 |
|
|
$ |
(414.8 |
) |
|
$ |
300.3 |
|
|
$ |
(265.0 |
) |
|
$ |
(225.0 |
) |
Cash flow items related to 2022 portfolio actions and asbestos entity sale transaction |
|
$ |
575.9 |
|
|
|
|
$ |
591.2 |
|
|
|
|
$ |
615.0 |
|
|
$ |
615.0 |
|
||||
Adjusted free cash flow |
|
$ |
137.3 |
|
|
|
|
$ |
176.4 |
|
|
|
|
$ |
350.0 |
|
|
$ |
390.0 |
|
We believe that each of the following non-GAAP measures provides useful information to investors regarding the Company’s financial conditions and operations:
- "Adjusted Operating Profit" and "Adjusted Operating Margin" add back to Operating Profit items which are outside of our core performance, some of which may or may not be non-recurring, and which we believe may complicate the interpretation of the Company’s underlying earnings and operational performance. These items include income and expense such as: the loss on divestiture of asbestos-related assets and liabilities, transaction related expenses, and repositioning related (gains) charges. These items are not incurred in all periods, the size of these items is difficult to predict, and none of these items are indicative of the operations of the underlying businesses. We believe that non-GAAP financial measures that exclude these items provide investors with an alternative metric that can assist in predicting future earnings and profitability that are complementary to GAAP metrics.
- "Adjusted Net Income" and "Adjusted EPS" exclude items which are outside of our core performance, some of which may or may not be non-recurring, and which we believe may complicate the presentation of the Company’s underlying earnings and operational performance. These measures include income and expense items that impacted Operating Profit such as: the loss on divestiture of asbestos-related assets and liabilities, transaction related expenses, and repositioning related (gains) charges. Additionally, these non-GAAP financial measures exclude income and expense items that impacted Net Income and Earnings per Diluted Share such as: interest expense on the 364 Day Credit Agreement related to the asbestos transaction, tax benefit related to the divestiture of asbestos-related assets and liabilities, the impact of pension curtailments and settlements, gain on the sale of business, deferred tax adjustment related to sale of business, and gain on the sale of property. These items are not incurred in all periods, the size of these items is difficult to predict, and none of these items are indicative of the operations of the underlying businesses. We believe that non-GAAP financial measures that exclude these items provide investors with an alternative metric that can assist in predicting future earnings and profitability that are complementary to GAAP metrics.
- “Free Cash Flow” and “Adjusted Free Cash Flow” provide supplemental information to assist management and investors in analyzing the Company’s ability to generate liquidity from its operating activities. The measure of free cash flow does not take into consideration certain other non-discretionary cash requirements such as, for example, mandatory principal payments on the Company’s long-term debt. Free Cash Flow is calculated as cash provided by operating activities less capital spending. Adjusted Free Cash Flow is calculated as Free Cash Flow adjusted for certain cash items which we believe may complicate the interpretation of the Company’s underlying free cash flow performance such as certain transaction related cash flow items related to 2022 portfolio actions and the divestiture of asbestos-related assets and liabilities. These items are not incurred in all periods, the size of these items is difficult to predict, and none of these items are indicative of the operations of the underlying businesses. We believe that non-GAAP financial measures that exclude these items provide investors with an alternative metric that can assist in predicting future cash flows that are complementary to GAAP metrics.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221024005649/en/
Vice President, Investor Relations
203-363-7329
www.craneco.com
Source:
FAQ
What were Crane Holdings' Q3 2022 financial results?
What is the adjusted EPS guidance for Crane Holdings for 2022?
How did Crane Holdings' core order growth perform in Q3 2022?
What impact did the divestiture have on Crane Holdings' sales?